Effectiveness of High Flow Oxygen Therapy in Patients With Hematologic Malignancy Acute Hypoxemic Respiratory Failure

NACompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

November 1, 2016

Primary Completion Date

September 14, 2018

Study Completion Date

September 14, 2018

Conditions
Acute Hypoxemic Respiratory FailureHematologic Malignancy
Interventions
DEVICE

High flow oxygen therapy

High-flow nasal oxygen \[HFNO\] therapy is a focus of growing attention as an alternative to standard oxygen therapy. By providing warmed and humidified gas, HFNO allows the delivery of higher flow rates \[of up to 60 L/min\] via nasal cannula devices, with fraction of inspired oxygen(FiO2) values of nearly 100%.

Trial Locations (1)

38039

Erciyes University Medical School, Kayseri

All Listed Sponsors
lead

Kursat Gundogan

OTHER

NCT03133520 - Effectiveness of High Flow Oxygen Therapy in Patients With Hematologic Malignancy Acute Hypoxemic Respiratory Failure | Biotech Hunter | Biotech Hunter